Antiparkinsonian efficacy of a novel transdermal delivery system for (+)-PHNO in MPTP-treated squirrel monkeys.

Antiparkinsonian efficacy of a novel transdermal delivery system for (+)-PHNO in MPTP-treated squirrel monkeys.

We examined the ability of the antiparkinsonian agent (+)-4-propyl-9-hydroxynaphthoxazine (PHNO) to enter the systemic circulation in therapeutic concentrations after continuous transdermal absorption in squirrel monkeys rendered parkinsonian by MPTP. Direct subcutaneous administration of (+)-PHNO i...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Rupniak, N, Tye, S, Jennings, C, Loper, A, Bondi, J, Hichens, M, Hand, E, Iversen, S, Stahl, S
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	1989

Míreanna comhchosúla

Therapeutic efficacy of a novel transdermal delivery system for (+)-PHNO in parkinsonian squirrel monkeys.
de réir: Rupniak, N, et al.
Foilsithe / Cruthaithe: (1989)

(+)-PHNO: a new anti-parkinsonian agent which does not induce chorea in MPTP-treated squirrel monkeys.
de réir: Rupniak, N, et al.
Foilsithe / Cruthaithe: (1990)

Characterisation of dyskinesias induced by L-dopa in MPTP-treated squirrel monkeys.
de réir: Boyce, S, et al.
Foilsithe / Cruthaithe: (1990)

DIFFERENTIAL-EFFECTS OF D-1 AND D-2 DOPAMINE AGONISTS IN MPTP-TREATED SQUIRREL-MONKEYS
de réir: Boyce, S, et al.
Foilsithe / Cruthaithe: (1990)

NB-355: a novel prodrug for L-DOPA with reduced risk for peak-dose dyskinesias in MPTP-treated squirrel monkeys.
de réir: Tye, S, et al.
Foilsithe / Cruthaithe: (1989)

Nigrostriatal damage is required for induction of dyskinesias by L-DOPA in squirrel monkeys.
de réir: Boyce, S, et al.
Foilsithe / Cruthaithe: (1990)

CCK-8S inhibits L-dopa-induced dyskinesias in parkinsonian squirrel monkeys.
de réir: Boyce, S, et al.
Foilsithe / Cruthaithe: (1990)

BLOCKADE OF CCK-B RECEPTORS BY L-365,260 INDUCES ANALGESIA IN THE SQUIRREL-MONKEY
de réir: Oneill, M, et al.
Foilsithe / Cruthaithe: (1990)

Differential effects of D1 and D2 agonists in MPTP-treated primates: functional implications for Parkinson's disease.
de réir: Boyce, S, et al.
Foilsithe / Cruthaithe: (1990)

Blockade of CCK-B receptors by L-365,260 induces analgesia in the squirrel monkey.
de réir: O'Neill, M, et al.
Foilsithe / Cruthaithe: (1990)

Differential effects of D1 and D2 agonists in MPTP-treated primates: functional implications for Parkinson's disease. 1990.
de réir: Boyce, S, et al.
Foilsithe / Cruthaithe: (2001)

Weak antiparkinsonian activity of the D1 agonist C-APB (SKF 82958) and lack of synergism with a D2 agonist in primates.
de réir: Rupniak, N, et al.
Foilsithe / Cruthaithe: (1992)

Experimental infection of squirrel monkeys with nipah virus
de réir: Marianneau, P., et al.
Foilsithe / Cruthaithe: (2010)

Spatial orientation in the squirrel monkey : an experimental and theoretical investigation
de réir: Merfeld, Daniel Michael
Foilsithe / Cruthaithe: (2005)

Spontaneous orofacial dyskinesias in a captive cynomolgus monkey: implications for tardive dyskinesia.
de réir: Rupniak, N, et al.
Foilsithe / Cruthaithe: (1990)

The cholecystokinin receptor antagonist devazepide enhances morphine-induced analgesia but not morphine-induced respiratory depression in the squirrel monkey.
de réir: Dourish, C, et al.
Foilsithe / Cruthaithe: (1990)

Long-term motor stimulant effects of (+)-4-propyl-9-hydroxynaphthoxazine (PHNO), a dopamine D-2 receptor agonist: interactions with a dopamine D-1 receptor antagonist and agonist.
de réir: Martin-Iverson, M, et al.
Foilsithe / Cruthaithe: (1988)

Effects of group-based enrichment on the behaviour of squirrel monkeys (Saimiri sciureus) at the Singapore Zoo.
de réir: Han, Sharleen Niyan.
Foilsithe / Cruthaithe: (2009)

Effects of different environmental enrichment devices on cage stereotypies and autoaggression in captive cynomolgus monkeys.
de réir: Bryant, C, et al.
Foilsithe / Cruthaithe: (1988)

Induction of cognitive impairment by scopolamine and noncholinergic agents in rhesus monkeys.
de réir: Rupniak, N, et al.
Foilsithe / Cruthaithe: (1991)

Antiparkinsonian medication masks motor signal progression in de novo patients
de réir: Brzezicki, MA, et al.
Foilsithe / Cruthaithe: (2023)

Failure of intravenous pentagastrin challenge to induce panic-like effects in rhesus monkeys.
de réir: Rupniak, N, et al.
Foilsithe / Cruthaithe: (1993)

Dystonia induced by combined treatment with L-dopa and MK-801 in parkinsonian monkeys.
de réir: Rupniak, N, et al.
Foilsithe / Cruthaithe: (1992)

Comparison of the effects of selective and nonselective muscarinic agonists on cognition and thermoregulation in primates.
de réir: Rupniak, N, et al.
Foilsithe / Cruthaithe: (1992)

Drug-induced purposeless chewing: animal model of dyskinesia or nausea?
de réir: Rupniak, N, et al.
Foilsithe / Cruthaithe: (1990)

INVOLVEMENT OF THE MONKEY HIPPOCAMPUS IN MEMORY FOR MOVEMENTS
de réir: Rupniak, N, et al.
Foilsithe / Cruthaithe: (1987)

MPTP, impairment of motor performance and amine accumulation in Macaca fascicularis.
de réir: Willis, G, et al.
Foilsithe / Cruthaithe: (1987)

Monkey hippocampus and learning about spatially directed movements.
de réir: Rupniak, N, et al.
Foilsithe / Cruthaithe: (1987)

Imaging dopamine receptors in humans with [11C]-(+)-PHNO: dissection of D3 signal and anatomy.
de réir: Tziortzi, A, et al.
Foilsithe / Cruthaithe: (2011)

Synthesis and antiparkinsonian activity of nanocomposite of chitosan-tripolyphosphate-Mucuna pruriens L extract (CS-TPP-MP)
de réir: Sardjono, R. E., et al.
Foilsithe / Cruthaithe: (2020)

The spatial spread of the grey squirrel in Britain
de réir: Maini, P, et al.
Foilsithe / Cruthaithe: (1991)

On the spatial spread of the grey squirrel in Britain.
de réir: Okubo, A, et al.
Foilsithe / Cruthaithe: (1989)

On the spatial spread of the grey squirrel in Britain
de réir: Okubo, A, et al.
Foilsithe / Cruthaithe: (1989)

Development of marked striatal hand with antiparkinsonian medication withdrawal during traditional (Ayurvedic) medicine treatment for Parkinson's disease
de réir: Lim, Shen-Yang, et al.
Foilsithe / Cruthaithe: (2010)

Transdermal theranostics
de réir: Than, Aung, et al.
Foilsithe / Cruthaithe: (2021)

Anxiolytic-like and antinociceptive effects of MK-801 accompanied by sedation and ataxia in primates.
de réir: Rupniak, N, et al.
Foilsithe / Cruthaithe: (1993)

Modulatory role for CCK-B antagonists in Parkinson's disease.
de réir: Boyce, S, et al.
Foilsithe / Cruthaithe: (1990)

MPTP-induced mouse model of Parkinson’s disease: a promising direction for therapeutic strategies
de réir: Mustapha, Musa, et al.
Foilsithe / Cruthaithe: (2021)

MPTP- induced Balb/c mice recapitulate compensatory Parkinson’s-like motor features
de réir: Mustapha, Musa, et al.
Foilsithe / Cruthaithe: (2024)

Inhibitors of type IV phosphodiesterases reduce the toxicity of MPTP in substantia nigra neurons in vivo.
de réir: Hulley, P, et al.
Foilsithe / Cruthaithe: (1995)